BenevolentAI unites technology with human intelligence to re-engineer drug discovery and deliver life-changing medicines. We have developed the Benevolent Platform®, a drug discovery platform built on powerful data foundations with state of the art machine learning and AI technology. Our technology empowers scientists to decipher the vast and complex code underlying human biology, find new ways to treat disease and personalise medicines to patients. Benevolent has active in-house R&D drug programmes in disease areas such as neurodegeneration, immunology, oncology and inflammation and has research and commercial collaborations with leading pharmaceutical and research organisations. The company is headquartered in London with a research facility in Cambridge (UK) and a further office in New York.
We are an eclectic bunch at Benevolent, united by our belief that innovative thinking and purposeful technology can truly change outcomes for the better. Our mission is to re-engineer drug discovery and deliver life-changing medicines for patients in need and we do this by applying AI, machine learning and other advanced technologies to reinvent the ways drugs are discovered and developed. We strive to bring together unique skills and perspectives across biology, chemistry, engineering, AI research, informatics, precision medicine and drug discovery.
We are looking for a highly experienced medicinal chemist at Senior Principal Scientist level. As a key part of our Chemical Sciences team, you will be responsible for working closely with senior cheminformatics, AI, machine learning, engineering and product development leaders to help shape the development of our proprietary computational platform to maximise its impact on Drug Discovery programmes at all stages from target identification through to Candidate selection.
Our state-of-the-art platform utilises novel machine learning, cheminformatic and computational chemistry techniques to transform the way targets and binding sites are prioritised, early hit matter is identified and complex molecular optimisations across ADMET space are performed. Working closely with the senior product manager, the candidate will bring their wide-ranging experience and knowledge of Drug Discovery to help prioritise the development of our platform to best impact on our diverse portfolio.
As an experienced medicinal chemist, a further part of the role will be direct contribution to programmes from Hit Identification through to Candidate delivery in either a chemistry or project leadership capacity.
The successful Candidate will be working to support small molecule Drug Discovery at our headquarters in London devising creative ways to reimagine the way medicines are discovered.
Together, we envision a world in which no disease goes untreated. If you are benevolent, curious, want to tackle real world problems and are willing to embrace new ideas, hit that ‘apply’ button and join us.
It has come to our attention that unfortunately fraudsters have been falsely offering jobs and set-up fake interviews under the guise of being a Benevolent recruiter. We therefore advise you to be very stringent about who is reaching out to you. Any enquiry from our team will only be made via the email careers@benevolent.ai or an email from this domain @benevolent.ai. Please flag any suspicious contact request to hello@benevolent.ai